Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 36 (3) , 343-354
- https://doi.org/10.1016/0090-6980(88)90075-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in manJournal of Allergy and Clinical Immunology, 1988
- PAF AntagonistsDrugs, 1988
- PAF closely mimics pathology of asthmaTrends in Pharmacological Sciences, 1987
- Metabolism of platelet-activating factor in isolated perfused rat lung.Journal of Clinical Investigation, 1987
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MANThe Lancet, 1986
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pigBiochemical and Biophysical Research Communications, 1985
- Desensitization of human platelets by platelet activating factorBiochemical and Biophysical Research Communications, 1985
- Carbacyclin — A potent stable prost acyclin analogue for the inhibition of platelet aggregationProstaglandins, 1980